Plaque burden, intravascular ultrasound, and distal embolization phenomenon.

aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department (from the PRIDE study). Am J Cardiol 2007;100:1336–40. 4. Azevedo A, Bettencourt P, Pimenta J, et al. Clinical syndrome suggestive of heart failure is frequently attributable to non-cardiac disorders—population-based study. Eur J Heart Fail 2007;9:391–6. 5. Androne AS, Hryniewicz K, Hudaihed A, et al. Relation of unrecognised hypervolaemia in chronic heart failure to clinical status, haemodynamics, and patient outcomes. Am J Cardiol 2004;93:1254–9. 6. Chakko S, Woska D, Martinez H, et al. Clinical, radiographic, and haemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. Am J Med 1991;90: 353–9. 7. Black ER, Panzer RJ, Mayewski RJ, Griner PF. Characteristics of diagnostic tests and principles for their use in quantitative decision making. In: Panzer RJ, Black ER, Griner PF, editors. Diagnostic Strategies for Common Medical Problems. Philadelphia, PA: American College of Physicians 1991:1–16. 8. Wu AH, Smith A, Wieczorek S, et al. Biological variation for N-terminal proand B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 2003;92:628–31. 9. Tang WHW, Girod JP, Lee MJ, et al. Plasma B-type peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation 2003;108:2964–6. 10. Pruszczyk P. N-terminal pro-brain natriuretic peptide as an indicator of right ventricular dysfunction. J Card Fail 2005;11 Suppl:S65–9. 11. Leuchte HH, Baumgartner RA, Nounou ME, et al. Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am J Respir Crit Care Med 2006;173:744–50.